Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Hogenboom L, Schoof LG, Gelissen LMY, Mostert J, van Rooij L, Hoitsma E, van Munster CEP, van Eijk J, Kalkers NF, Adriani KS, et al.

Eur J Neurol. 2026 Jul; 33(7):e70695. PMID: 42411923. Abstract